Search Result for 'N-Nitrosamine'

Abstract The detection of  N-nitrosamine impurities in medicines and the recent emergence of nitrosamine drug substance related impurities (NDSRIs) has ...

N-nitrosamines are likely human carcinogens. After  N-nitrosamine contaminants were detected in pharmaceutical products in 2018, regulatory authorities set a framework for ...

Abstract This work focused on N-nitroso-fluoxetine, a N-nitrosamine drug substance-related impurity (NDSRI) formed in fluoxetine-containing products via nitrosation pathways. N-nitroso-fluoxetine ...

to biological and pharmacokinetic complexities. Factors like absorption, distribution, clearance, and metabolism within physiological conditions could all influence the potency ...

to consider the formation of N-nitrosamines in a solid drug product. The conservative assumptions made in defining the reactant concentrations bias ...

a call for review to MAHs on 19 September 2019 requesting the review of human medicines containing chemically synthesized DSs ...

Abstract N-nitrosamines are a class of compounds belonging to the “cohort of concern” and characterized by the linkage of a ...

of the cohort-of-concern carcinogens according to the ICH M7 guideline, as some of them of are known potent rodent carcinogens ...

The potential for  N-nitrosamine impurities in pharmaceutical products presents a challenge for the quality management of medicinal products. N-Nitrosamines are considered ...